B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma

Ji Ye Kim, Sung Im Do, Go Eun Bae, Hyun Soo Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A better understanding of tumor biology is important in the identification of molecules that are downregulated in malignancy and in determining their role in tumor suppression. B-cell translocation gene 1 (BTG1) has been shown to act as a tumor suppressor in several types of human malignancy. In this study, we analyzed BTG1 expression in ovarian carcinoma cell lines, and we investigated the mechanism underlying the observed alterations. The methylation status of the BTG1 promoter region was determined by methylation-specific polymerase chain reaction, and the effect of demethylation on BTG1 expression was analyzed. BTG1 protein expression in ovarian high-grade serous carcinoma tissue samples was evaluated using immunohistochemistry. BTG1 mRNA and protein expression were reduced in ovarian carcinoma cells. In BTG1-silenced ovarian cancer cells, the BTG1 promoter was highly methylated. Treatment with 5-aza-deoxycytidine significantly elevated BTG1 mRNA and protein expression. Immunostaining demonstrated that BTG1 expression was significantly lower in ovarian carcinoma tissue samples than nonpathological ovaries and fallopian tubes. We demonstrated that BTG1 silencing in ovarian carcinoma occurs through epigenetic repression and is involved in the ovarian carcinogenesis. Our data suggest that BTG1 is a potential therapeutic target for patients with ovarian carcinoma.

Original languageEnglish
Article number21037
JournalJournal of Cancer
Volume8
Issue number14
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Methylation
B-Lymphocytes
Down-Regulation
Carcinoma
Genes
Neoplasms
Gene Expression
Epigenetic Repression
Deoxycytidine
Messenger RNA
Proteins
Fallopian Tubes
Gene Silencing
Genetic Promoter Regions
Ovarian Neoplasms
Ovary
Carcinogenesis
Immunohistochemistry
Cell Line
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{b214df0985214ca9987502c1f6b9859a,
title = "B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma",
abstract = "A better understanding of tumor biology is important in the identification of molecules that are downregulated in malignancy and in determining their role in tumor suppression. B-cell translocation gene 1 (BTG1) has been shown to act as a tumor suppressor in several types of human malignancy. In this study, we analyzed BTG1 expression in ovarian carcinoma cell lines, and we investigated the mechanism underlying the observed alterations. The methylation status of the BTG1 promoter region was determined by methylation-specific polymerase chain reaction, and the effect of demethylation on BTG1 expression was analyzed. BTG1 protein expression in ovarian high-grade serous carcinoma tissue samples was evaluated using immunohistochemistry. BTG1 mRNA and protein expression were reduced in ovarian carcinoma cells. In BTG1-silenced ovarian cancer cells, the BTG1 promoter was highly methylated. Treatment with 5-aza-deoxycytidine significantly elevated BTG1 mRNA and protein expression. Immunostaining demonstrated that BTG1 expression was significantly lower in ovarian carcinoma tissue samples than nonpathological ovaries and fallopian tubes. We demonstrated that BTG1 silencing in ovarian carcinoma occurs through epigenetic repression and is involved in the ovarian carcinogenesis. Our data suggest that BTG1 is a potential therapeutic target for patients with ovarian carcinoma.",
author = "Kim, {Ji Ye} and Do, {Sung Im} and Bae, {Go Eun} and Kim, {Hyun Soo}",
year = "2017",
month = "1",
day = "1",
doi = "10.7150/jca.21037",
language = "English",
volume = "8",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "14",

}

B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma. / Kim, Ji Ye; Do, Sung Im; Bae, Go Eun; Kim, Hyun Soo.

In: Journal of Cancer, Vol. 8, No. 14, 21037, 01.01.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma

AU - Kim, Ji Ye

AU - Do, Sung Im

AU - Bae, Go Eun

AU - Kim, Hyun Soo

PY - 2017/1/1

Y1 - 2017/1/1

N2 - A better understanding of tumor biology is important in the identification of molecules that are downregulated in malignancy and in determining their role in tumor suppression. B-cell translocation gene 1 (BTG1) has been shown to act as a tumor suppressor in several types of human malignancy. In this study, we analyzed BTG1 expression in ovarian carcinoma cell lines, and we investigated the mechanism underlying the observed alterations. The methylation status of the BTG1 promoter region was determined by methylation-specific polymerase chain reaction, and the effect of demethylation on BTG1 expression was analyzed. BTG1 protein expression in ovarian high-grade serous carcinoma tissue samples was evaluated using immunohistochemistry. BTG1 mRNA and protein expression were reduced in ovarian carcinoma cells. In BTG1-silenced ovarian cancer cells, the BTG1 promoter was highly methylated. Treatment with 5-aza-deoxycytidine significantly elevated BTG1 mRNA and protein expression. Immunostaining demonstrated that BTG1 expression was significantly lower in ovarian carcinoma tissue samples than nonpathological ovaries and fallopian tubes. We demonstrated that BTG1 silencing in ovarian carcinoma occurs through epigenetic repression and is involved in the ovarian carcinogenesis. Our data suggest that BTG1 is a potential therapeutic target for patients with ovarian carcinoma.

AB - A better understanding of tumor biology is important in the identification of molecules that are downregulated in malignancy and in determining their role in tumor suppression. B-cell translocation gene 1 (BTG1) has been shown to act as a tumor suppressor in several types of human malignancy. In this study, we analyzed BTG1 expression in ovarian carcinoma cell lines, and we investigated the mechanism underlying the observed alterations. The methylation status of the BTG1 promoter region was determined by methylation-specific polymerase chain reaction, and the effect of demethylation on BTG1 expression was analyzed. BTG1 protein expression in ovarian high-grade serous carcinoma tissue samples was evaluated using immunohistochemistry. BTG1 mRNA and protein expression were reduced in ovarian carcinoma cells. In BTG1-silenced ovarian cancer cells, the BTG1 promoter was highly methylated. Treatment with 5-aza-deoxycytidine significantly elevated BTG1 mRNA and protein expression. Immunostaining demonstrated that BTG1 expression was significantly lower in ovarian carcinoma tissue samples than nonpathological ovaries and fallopian tubes. We demonstrated that BTG1 silencing in ovarian carcinoma occurs through epigenetic repression and is involved in the ovarian carcinogenesis. Our data suggest that BTG1 is a potential therapeutic target for patients with ovarian carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85028464993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028464993&partnerID=8YFLogxK

U2 - 10.7150/jca.21037

DO - 10.7150/jca.21037

M3 - Article

AN - SCOPUS:85028464993

VL - 8

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 14

M1 - 21037

ER -